Lisa Bengtson, RN, M.S.N., OCN

Lisa Bengtson, R.N., M.S.N., O.C.N., is the Nurse Consultant for the Lung and Upper Aerodigestive Cancer Research Group (LUARCG) in the Division of Cancer Prevention at the National Cancer Institute. As the LUARCG Nurse Consultant, Lisa is involved in the development and oversight of early phase Lung and Upper Aerodigestive cancer chemoprevention trials. Lisa is also the co-Project Officer for the Clinical Trials Accrual Quality Improvement Program (AQuIP) Data and Information Technology Support contract for the US-Latin American-Caribbean HIV/HPV Prevention Clinical Trials Network (ULACNet) and serves as the primary Liaison between CP-CTNet and DCP’s Regulatory Contractor. She has over 10 years of oncology research experience in the NCI’s intramural and extramural programs with over 20 years of experience in medical oncology physician practices and community cancer centers and has been an Oncology Certified Nurse for 34 years. Lisa received her Bachelor of Science in Nursing at the Catholic University of America and her Master’s in Nursing Administration from the University of Texas at Arlington. Lisa received the University of Texas Student Award for Outstanding Clinical Performance and the NIH Award of Merit for work on the development of anti-mesothelin immunotoxin therapy for Malignant Mesothelioma.